by John on (#5AEXD)
Both Pfizer and Moderna have announced recently that their SARS-COV2 vaccine candidates reduce the rate of infection by over 90% in the active group compared to the control (placebo) group. That’s great news. The vaccines may turn out to be less than 90% effective when all is said and done, but even so they’re likely […]The post Good news from Pfizer and Moderna first appeared on John D. Cook.